April 22, 2026 · Form 4 insider transaction
Chadwick Jeremy G bought 200 shares of Kymera Therapeutics, Inc. at $43.50 per share, a transaction worth $8.7K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
These transactions were effected pursuant to a Rule 10b5-1 trading plan dated December 10, 2025 adopted by the reporting person.